TABLE 3.
CAUSES OF TREATMENT FAILURES IN AFRICAN AMERICANS AND WHITES IN ACRN STUDIES
African American (n = 46) | White (n = 101) | ||
Reason | N (%) | N (%) | P Value |
Asthma exacerbation | 21 (45.7) | 61 (60.4) | 0.1091 |
Use of inhaled, oral, parental steroids for increased asthma symptoms | 20 (43.5) | 60 (59.4) | 0.0776 |
Emergency treatment or hospitalization at a medical facility for an acute asthma exacerbation | 5 (10.9) | 6 (5.9) | 0.3205 |
Decreased lung function (defined as 20% fall in FEV1 from baseline or a 35% fall in peak expiratory flow from baseline on two of three consecutive [twice daily] measurements) | 7 (15.2) | 23 (22.8) | 0.3791 |
Increased asthma rescue medication use (defined as use of 8 puffs per 24 h over baseline use for a period of 48 h, or ≥ 16 puffs per 24 h for 48 h) | 32 (69.6) | 47 (46.5) | 0.0123* |
Physician clinical judgment for safety reasons | 16 (34.8) | 50 (49.5) | 0.1098 |
Definition of abbreviation: ACRN = Asthma Clinical Research Network.
Data are not mutually exclusive. Each individual treatment failure could have been attributable to more than one reason.
P value < 0.05, Fisher exact test.